Children who undergo treatment for JMML, especially those who receive HSCT, require long-term follow-up care to monitor for potential complications. This can include: - Regular blood tests to monitor for relapse - Monitoring for graft-versus-host disease (GVHD) in transplant recipients - Supportive care to manage treatment side effects and improve quality of life
